Perry W. Sweeten

Developing a dashboard for benchmarking the productivity of a medication therapy management program.

Kristina A. Dittrich, L. Odell, A. Umbreit, 2017, Journal of the American Pharmacists Association : JAPhA.

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019

Ryan J. Anderson, R. Razonable, Ravindra Ganesh, 2022, Mayo Clinic Proceedings.

Curbing the Delta Surge

S. Tulledge-Scheitel, R. Razonable, Ravindra Ganesh, 2022, Mayo Clinic Proceedings.

A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19

Karen J. Reinschmidt, S. Tulledge-Scheitel, L. Lutwick, 2021, Mayo Clinic Proceedings.